NewBridge Pharmaceuticals

NewBridge Pharmaceuticals is a biotech company in Dubai, United Arab Emirates, founded in 2010. It has raised $12.0M across 1 round, most recently a $12.0M Series B in September 2010.

Accessing Innovation Saving Lives

Headquarters
Dubai, Dubai
Employees
201–500
Founded
2010
Business Model
B2B
Total Funding
$12.0M
Last Round
$12.0M Series BSep 2010
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

NewBridge Pharmaceuticals operates a commercialization platform focused on in-licensing innovative therapies developed by global pharmaceutical businesses. Its mission is to bridge the access gap in MENA countries, with the aim of saving and transforming the lives of patients and their families through access to those therapies.

Summary

It lists 201–500 employees. It has raised $12.0M in total across 1 round, most recently a $12.0M Series B round in Sep 2010.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BSep 2010
$12.0M

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NewBridge Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/newbridge-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/newbridge-pharmaceuticals" alt="NewBridge Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>